跳转至内容
Merck

Coenzyme Q in pregnant women and rats with intrahepatic cholestasis.

Liver international : official journal of the International Association for the Study of the Liver (2013-10-15)
Manuela R Martinefski, Mario D Contin, Myrian R Rodriguez, Estefanía M Geréz, Mónica L Galleano, Silvia E Lucangioli, Liliana G Bianciotti, Valeria P Tripodi
摘要

Intrahepatic cholestasis of pregnancy is a high-risk liver disease given the eventual deleterious consequences that may occur in the foetus. It is accepted that the abnormal accumulation of hydrophobic bile acids in maternal serum are responsible for the disease development. Hydrophobic bile acids induce oxidative stress and apoptosis leading to the damage of the hepatic parenchyma and eventually extrahepatic tissues. As coenzyme Q (CoQ) is considered an early marker of oxidative stress in this study, we sought to assess CoQ levels, bile acid profile and oxidative stress status in intrahepatic cholestasis. CoQ, vitamin E and malondialdehyde were measured in plasma and/or tissues by HPLC-UV method whereas serum bile acids by capillary electrophoresis in rats with ethinyl estradiol-induced cholestasis and women with pregnancy cholestasis. CoQ and vitamin E plasma levels were diminished in both rats and women with intrahepatic cholestasis. Furthermore, reduced CoQ was also found in muscle and brain of cholestatic rats but no changes were observed in heart or liver. In addition, a positive correlation between CoQ and ursodeoxycholic/lithocholic acid ratio was found in intrahepatic cholestasis suggesting that increased plasma lithocholic acid may be intimately related to CoQ depletion in blood and tissues. Significant CoQ and vitamin E depletion occur in both animals and humans with intrahepatic cholestasis likely as the result of increased hydrophobic bile acids known to produce significant oxidative stress. Present findings further suggest that antioxidant supplementation complementary to traditional treatment may improve cholestasis outcome.

材料
货号
品牌
产品描述

Sigma-Aldrich
丙二醇, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
胆红素, ≥98% (EmM/453 = 60), powder
USP
丙二醇, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
1,2-丙二醇, ACS reagent, ≥99.5%
Sigma-Aldrich
丙二醇, meets USP testing specifications
Supelco
丙二醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
胆红素, purum, ≥95.0% (UV)
Sigma-Aldrich
1,2-丙二醇, ReagentPlus®, 99%
Sigma-Aldrich
1,2-丙二醇, puriss. p.a., ACS reagent, ≥99.5% (GC)
Supelco
1,2-丙二醇, analytical standard
Sigma-Aldrich
1,2-丙二醇, meets analytical specification of Ph. Eur., BP, USP, ≥99.5%
丙二醇, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
1,2-丙二醇, tested according to Ph. Eur.
Sigma-Aldrich
1,2-丙二醇, SAJ special grade, ≥99.0%
Sigma-Aldrich
1,2-丙二醇, SAJ first grade, ≥99.0%